Norstella/Pharma Intelligence U.K. Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Norstella/Pharma Intelligence U.K. Limited - overview
Established
2022
Location
-, -, US
Primary Industry
Pharmaceuticals
About
Based in the US, and founded in 2022, Norstella/Pharma Intelligence U. K. Limited is formed by the merger of Managed Markets Insight & Technology, LLC, also known as Norstella and Pharma Intelligence U. K.
Limited, to provide medicine clients a full range of commercial and clinical solutions. In June 2022, Managed Markets Insight & Technology, LLC, a portfolio company of Welsh, Carson, Anderson & Stowe, merged with Citeline. The company offers help to pharmaceutical manufacturers not only in clinical trials but at every stage of drug development to plan for and overcome the barriers. Additionally, the firm offers specialized treatment for all types of diseases including oncology and rare disease.
Current Investors
Hg, Warburg Pincus, Mubadala Investment Company
Primary Industry
Pharmaceuticals
Sub Industries
Business Support Services, Healthcare IT, Pharmaceuticals
Verticals
HealthTech
Company Stage
Merged
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.